Evidence-based medicine
WHO Issues New Guidelines for HIV Prevention and Treatment: Embracing Injectable Lenacapavir as a Powerful Tool in the Fight Against AIDS
The World Health Organization (WHO) has released new guidelines recommending the use of injectable lenacapavir (LEN) as an additional pre-exposure prophylaxis (PrEP) option for HIV prevention, alongside daily oral pills and other shorter-acting options. LEN, the first twice-yearly injectable PrEP product, offers a highly effective, long-acting alternative that can be